Oracle Corporation: Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs

SYDNEY, AU, Sept 6, 2022 - (ACN Newswire) - Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates, enabling

Related Keywords

Australia ,United States ,New Zealand ,Sydney ,New South Wales ,America ,Australian ,American ,Chris Thompson ,Yvonne Lungershausen ,Sullivan Asia Pacific ,Research Associates ,Office Of The Gene Technology Regulator ,Riverside Company ,Ibm ,Oracle ,North America ,Avance Clinical Australia ,North American ,Avance Clinical ,Gene Technology Regulator ,Australian Advantage ,Leadership Award ,Later Phase ,Corporation ,Vance ,Linical ,Nnounces ,North ,Cquisition ,Xpand ,Water ,Hase ,Services ,Biotechs ,